drugset / Trial / NCT01731730
Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The objectives of this proof of concept study are to evaluate the safety and preventive analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection in patients undergoing unilateral total knee arthroplasty.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-10
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivoligide | Unknown | 110 mg | Intrathecal |
| Subject | Brivoligide | Unknown | 330 mg | Intrathecal |
Indications
No indication recorded.